Shenzhen CAS-Originated Neurotech Firm Zhongke Huayi Secures Pre-A and Pre-A+ Funding for Non-Invasive Brain-Computer Interface Platform

Nov 25, 2024 14:33 CST Updated 14:33

NeurPlus

Precision EEG Measurement and Intelligent Wearable Medical Device Developer

Industry Information

According to the Biotechnology Transformation Network：Recently, NeurPlus announced that it has successfully completed Pre-A and Pre-A+ rounds of financing amounting to tens of millions of RMB. The investment was jointly participated by Taiyu Investment, CAS Angel, Seven Seas Capital, and Lincang Sinan Fund. The funds will mainly be used to accelerate the market expansion of approved non-invasive neuromodulation products such as transcranial electrical stimulators, develop new product pipelines, advance clinical trials, and expand the team, further enhancing NeurPlus's position in the field of non-invasive precise deep brain neuromodulation.

NeurPlusShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Brain Cognition and Brain Disease InstituteNeurPlus, established through incubation, focuses on the innovative development of non-invasive closed-loop neuromodulation technology. It builds a technology transformation platform to provide diverse intervention, treatment, and rehabilitation solutions for brain function disorders through physical intervention methods. Its product lines cover various mental and neurological disorders such as cognitive impairment, Alzheimer's disease, disorders of consciousness, epilepsy, depression, and autism.

As an innovative medical enterprise with cross-disciplinary integration, NeurPlus brings together multidisciplinary talents from fields such as neuroscience, psychology, materials science, and biomedical engineering. It has established a non-invasive closed-loop neuromodulation technology platform and innovatively developed the "BCI+tES" personalized neuromodulation solution.

Based on profound technical reserves, NeurPlus has made advancements in non-invasive neural stimulation positioning, closed-loop algorithms, integrated multi-channel stimulation chips, and electrode materials.Achieved multiple breakthroughs, laying a solid foundation for the comprehensive transformation from scientific research to clinical application.

With the advancement of technology, current neuromodulation techniques are trending towards precision, targeting, non-invasiveness, and closed-loop systems. NeurPlus focuses on individualized non-invasive deep brain precise closed-loop neuromodulation technology through the pathway of "BCI Brain-Computer Interface + tES Transcranial Electrical Stimulation," innovatively developing a closed-loop transcranial temporal interference deep brain stimulation device with fully independent intellectual property rights.

AsThe world's leading personalized non-invasive precise deep brain closed-loop modulation platform based on brain-computer interface,Closed-loop Transcranial Temporal Interference Deep Brain Stimulation Breakthrough in Technical Bottlenecks of Traditional Transcranial Electrical Stimulation

Transcranial Electrical Stimulator Receives Medical Device Registration Approval.This product is based on clinical expert consensus and guidelines, utilizing non-invasive neuroelectrical stimulation technology. Electrodes placed on the scalp deliver low-intensity current to the cerebral cortex, altering cortical excitability, enhancing synaptic plasticity, and influencing functional connectivity of neural networks. It delivers personalized and precise non-invasive electrical stimulation targeting the prefrontal cortex, combined with intelligent parameter configuration, offering a wide range of individualized modulation solutions for clinical use.

Transcranial Electrical Stimulator, Closed-loop Transcranial Temporal Interference Deep Electrical Stimulator, Animal Transcranial Electrical Stimulator

Source: NeurPlus

In the future, NeurPlus will continue to strengthen its technical advantages, accelerate market expansion in the field of non-invasive precise brain neuromodulation, and provide high-quality treatment solutions for patients with neurological disorders through multi-indication product layouts and platform technology innovation. The company is committed to promoting the global application and development of non-invasive neuromodulation technology.

-End-

About NeurPlus

Central-med Club is established byShangji TransformationInitiated, and jointlyMultiple listed companies、Frontline Investment InstitutionsThe biomedicine industry service platform, established in accordance with the "14th Five-Year Plan for Bioeconomy Development," follows the accelerating trend of global biotechnology evolution. It promotes the advancement and industrial application of biotechnology innovation through diversified services that facilitate the transfer and transformation of scientific and technological achievements. The platform supports companies in their rapid growth, serves their specialized and innovative development, and assists such enterprises in going public, aiming to create the most innovative and dynamic...Enterprise High-Quality Development Empowerment Platform”。

Welcome to scan the code to join NeurPlus Academy